Badrinath Konety Named UMP CEO & Vice Dean of Clinical Affairs
Dr. Badrinath Konety, MD, MBA, Head, Department of Urology has been named as the new CEO of University of Minnesota Physicians (UMP) and Vice Dean of Clinical Affairs for the Medical School.
Dr. Konety is a nationally and internationally recognized expert on prostate and bladder cancer and proven academic and clinical leader. He currently serves as the Dougherty Family Chair in Uro-Oncology, Director of the Institute for Prostate and Urologic Cancers, and the Medical School’s Associate Dean for Strategy and Innovation. He has also served on the UMP Board of Directors and as the Chair of the Board's Finance Committee. He co-led the Funds Flow workgroup during our negotiations with Fairview this summer and played a key role in our ability to co-create a new future.
As CEO, Dr. Konety will serve on the Executive Leadership Team of M Health Fairview and will oversee, with his dyad partners, service lines and shared clinical services throughout the health system. In addition, he will lead our work to further the UMP/Medical School operational alignment which will ensure the strength of the group practice and our capability to fulfill our land-grant mission to serve our state.
As Vice Dean of Clinical Affairs for the Medical School, Dr. Konety will build innovative clinical partnerships, develop and steward the Master Clinician track, play a key role in faculty recruitments, serve on the Dean’s leadership team, and lead in strategic planning efforts for the clinical mission.
In an email announcement, Dean Tolar said Dr. Konety “brings a successful academic track record, spirit of entrepreneurship, and a deep commitment to our practice and this Medical School.”
An interim chair for the Department of Urology will be named while a national search is conducted for a new permanent leader. Dr. Konety will assume his new role on December 1, 2018.
You may also like:
A deeper look into meeting the challenges of indigenous dementia in Native American and rural communities.
“It will be the most advanced surgical suite in the world,” said Dr. Chuck Dietz, Chair of the Department of Radiology.
In a perfect fit for the season of giving, Dr. Raja Kandaswamy, Director of Kidney and Pancreas Transplants in our Department of Surgery, recently conducted a kidney transplant between two colleagues from PreferredOne.
Dr. David Crawford invites Dr. Badrinath Konety to provide a counterpoint discussion on novel biomarkers and their use in detecting prostate cancer.
When Larson was diagnosed with prostate cancer, he wanted to find a treatment method with a short recovery time so he could get back to the things he enjoys.